BLACK DIAMOND THERAPEUTICS, INC. (BDTX) Total liabilities 2018–2025
BLACK DIAMOND THERAPEUTICS, INC. (BDTX) total liabilities at each fiscal year-end, per SEC filings.
$30.8MFY2025 · since FY2018: $6.6M → $30.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $30.8M | -21.7% |
| FY2024 | $39.4M | — |
| FY2020 | $21.9M | +349.1% |
| FY2019 | $4.9M | -26.1% |
| FY2018 | $6.6M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More BDTX financial trends
BDTX RevenueBDTX Net incomeBDTX Net marginBDTX Gross profitBDTX Gross marginBDTX Operating incomeBDTX Operating marginBDTX Operating cash flowBDTX Free cash flowBDTX Capital expendituresBDTX Return on equityBDTX Stock buybacksBDTX Dividends paidBDTX Total assetsBDTX Shareholders’ equityBDTX overview →